GOLDMAN SACHS GROUP INC
SEC insider (Form 3/4/5 filer). CIK 0000886982. Insider at Attovia Therapeutics, Inc. (ATTO) and 8 other issuers. 98 reported Form 4/5 transactions since Sep 2024; latest on Aug 6, 2026. Located in NEW YORK, NY.
Companies GOLDMAN SACHS GROUP INC has filed insider reports for
- Attovia Therapeutics, Inc. (ATTO)
- Old QVC Group, Inc. (QVCGP): 10% Owner
- Aperture AC (APUR): 10% Owner
- QuasarEdge Acquisition Corp (QRED): 10% Owner
- TGE Value Creative Solutions Corp (BEBE): 10% Owner
- Sweetgreen, Inc. (SG): 10% Owner
- INFLECTION POINT ACQUISITION CORP. IV (BACQ): 10% Owner
- Soho House & Co Inc. (SHCO): 10% Owner
- Sterling Check Corp. (STER): 10% Owner
GOLDMAN SACHS GROUP INC
CIK: 0000886982
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (9)
Attovia Therapeutics, Inc.
Old QVC Group, Inc.
Aperture AC
QuasarEdge Acquisition Corp
TGE Value Creative Solutions Corp
Sweetgreen, Inc.
INFLECTION POINT ACQUISITION CORP. IV
Soho House & Co Inc.
Sterling Check Corp.
Discretionary Trading P&L
Holdings
Transaction History (98 total)
- Aug 6, 2026ATTO
Attovia Therapeutics, Inc.
ConversionIndirect2M shares- - Aug 6, 2026ATTO
Attovia Therapeutics, Inc.
ConversionIndirect478.5K shares- - Aug 6, 2026ATTO
Attovia Therapeutics, Inc.
PurchaseIndirect500K shares at avg. $17.00$8.5M - Aug 5, 2026ATTO
Attovia Therapeutics, Inc.
SaleIndirect1.6K shares at avg. $22.06$34K - Aug 5, 2026ATTO
Attovia Therapeutics, Inc.
SaleIndirect1.3K shares at avg. $22.03$29K - Aug 5, 2026ATTO
Attovia Therapeutics, Inc.
SaleIndirect200 shares at avg. $22.05$4K - Aug 5, 2026ATTO
Attovia Therapeutics, Inc.
SaleIndirect988 shares at avg. $22.03$22K - Aug 5, 2026ATTO
Attovia Therapeutics, Inc.
SaleIndirect3.4K shares at avg. $22.02$75K - Aug 5, 2026ATTO
Attovia Therapeutics, Inc.
PurchaseIndirect85K shares at avg. $21.00$1.8M - Aug 5, 2026ATTO
Attovia Therapeutics, Inc.
SaleIndirect447 shares at avg. $21.87$10K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 6, 2026 | ATTO Attovia Therapeutics, Inc. | Conversion | 1,957,134 | - | $0 | Indirect |
| Aug 6, 2026 | ATTO Attovia Therapeutics, Inc. | Conversion | 478,498 | - | $0 | Indirect |
| Aug 6, 2026 | ATTO Attovia Therapeutics, Inc. | Purchase | 500,000 | $17.00 | $8,500,000 | Indirect |
| Aug 5, 2026 | ATTO Attovia Therapeutics, Inc. | Sale | 1,556 | $22.06 | $34,325 | Indirect |
| Aug 5, 2026 | ATTO Attovia Therapeutics, Inc. | Sale | 1,332 | $22.03 | $29,344 | Indirect |
| Aug 5, 2026 | ATTO Attovia Therapeutics, Inc. | Sale | 200 | $22.05 | $4,410 | Indirect |
| Aug 5, 2026 | ATTO Attovia Therapeutics, Inc. | Sale | 988 | $22.03 | $21,766 | Indirect |
| Aug 5, 2026 | ATTO Attovia Therapeutics, Inc. | Sale | 3,402 | $22.02 | $74,912 | Indirect |
| Aug 5, 2026 | ATTO Attovia Therapeutics, Inc. | Purchase | 85,000 | $21.00 | $1,785,000 | Indirect |
| Aug 5, 2026 | ATTO Attovia Therapeutics, Inc. | Sale | 447 | $21.87 | $9,776 | Indirect |
1-10 of 98 transactions